Eris Lifesciences Krishnakumar vaidyanathan as Executive resigns
Eris Lifesciences (ERIS) said Krishnakumar vaidyanathan as Executive has resigned. The company is valued at about ₹16,488 crore.
What happened
Eris Lifesciences (ERIS) told the exchanges on 5 October 2026 at 11:59 AM that Krishnakumar vaidyanathan as Executive has resigned.
From the filing: "Eris Lifesciences Limited has informed the Exchange regarding Resignation of Mr Krishnakumar vaidyanathan as Executive Director of the company w.e.f. close of September 30, 2026."
Company snapshot
Eris Lifesciences is a small-cap company in the Healthcare sector, with a market value of about ₹16,488 crore.
The stock last traded at ₹1,189.8, against a 52-week range of ₹1,162.9–₹1,740 (31.6% below the high).
Before this filing the shares had moved −7.7% over the month and −17.9% over three months. Average daily turnover over the last 20 sessions was about ₹11.21 crore.
Promoters held 54.14% at the end of Q1 FY27, up 0.22% points from the previous quarter; 16.85% of promoter shares were pledged. Foreign institutions owned 5.75% and domestic institutions 20.72%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 773 | 118 | 8.66 |
| Q2 FY26 | 792 | 120.2 | 8.82 |
| Q3 FY26 | 807 | 99.7 | 7.32 |
| Q4 FY26 | 757 | 281.6 | 20.6 |
| Q1 FY27 | 873 | 142.5 | 10.28 |
What history shows
BCEIE's records show 2 previous management change filings from the company since May 2026.
After those filings, the stock fell 3.6% on average the next trading day and was down 4.4% on average after five days (2 filings with price data).
Across 104 similar disclosures by other Healthcare companies, shares moved +1.0% on average the next day and +1.9% over five days; 50% of them rose the next day.
Market-wide, 3,852 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 21 Sept 2026 | Appointment of Mr as Non- Executive Independent Director of the… | −3.8% | — |
| 11 Sept 2026 | Resignation of Mr Krishnakumar Vaidyanathan as Executive Director of… | −3.3% | −4.4% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
- ERIS Share Price Today - Eris Lifesciences on NSE/BSE
- Eris Lifesciences drops 3% after acquiring India formulation business of Biocon arm
- Eris Lifesciences: Stock in focus after company partners with Natco Pharma to launch Semaglutide in India
- Eris Lifesciences 52 Week Low Streak and Peer Comparison
- Eris Lifesciences Appoints Akhil Awasthi as Independent Director for 5 Years
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.